Robo Global Healthcare Technology and Innovation ETF HTEC
45.75 USD +1.04 (+2.34%)
At closeNov 9, 2026, 5:10 PM EST
45.85 +0.11 +0.23%
After hours · Nov 9, 5:10 PM ET
44.83 Day range 45.93
31.85 52-week range 47.25
- YTD
- +29.52%
- 1 year
- +39.08%
News
etftrends.com 3 Reasons HTEC Stands Out Among the Best Health Tech ETFs Every day, headlines extoll the potential in AI investing, and the markets reflect that; the biggest companies in the S&P 500 include the key AI hyperscalers. Still, the impact of AI will be much…
etftrends.com Who's Buying the Future of AI & Robotics: 2026 M&A Report After several years of cooling appetite for M&A and large IPOs, 2026 has seen a resurgence in both, as well as increased appetite for venture fundraising in robotics and physical AI.
benzinga.com Axogen Prices Upsized $124 Million Stock Offering Axogen stock fell Thursday with a session volume of 1.92 million, priced its upsized underwritten public offering at $31.00 per share.
benzinga.com Trump's Weight-Loss Drug Push May Put These ETFs On A Diet Trump's vow to slash weight-loss drug prices sent Hims & Hers tumbling. These ETFs are facing new pressure.
benzinga.com Federal Judge Halts National Institutes of Health's Grant Policy Overhaul Citing Legal Violations A federal court blocked NIH's policy capping indirect cost rates on research grants, ruling it unlawful. The decision safeguards billions in funding and ongoing clinical trials.
benzinga.com DeepSeek Shakes Up AI Stocks: 3 Healthcare Tech ETFs Offer Stability, Innovation DeepSeek's AI model causes tech stocks to drop, but healthcare tech ETFs benefit from advancements in AI without vulnerability to market volatility.
benzinga.com Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024 According to the Global Data report, the pharma sector in Q3 2023 witnessed deals worth $28 billion, down 28% from the $54 billion recorded in Q2 2023.